Individually modifiable risk factors to ameliorate cognitive aging: A systematic review and meta-analysis

Climacteric

Volumn 18, Issue 5, 2015, Pages 678-689

  Lehert, P ^a,f   Villaseca, P ^b   Hogervorst, E ^c   Maki, P M ^d   Henderson, V W ^e  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^c LOUGHBOROUGH UNIVERSITY   (United Kingdom)

^d UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^e STANFORD UNIVERSITY   (United States)

^f UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

COGNITION; COGNITIVE ACTIVITY; COGNITIVE AGING; DEHYDROEPIANDROSTERONE; FOLATE; GINKGO BILOBA; ISOFLAVONES; MEDITERRANEAN DIET; MEMORY; MENOPAUSAL HORMONE THERAPY; META ANALYSIS; MINDFULNESS; OMEGA 3 FATTY ACIDS; PHYSICAL EXERCISE; SOCIAL ENGAGEMENT; SYSTEMATIC REVIEW; TAI CHI; VITAMIN B12; Vitamin D

Indexed keywords

ISOFLAVONE; OLIVE OIL;

AGING; ARTICLE; BENTON VISUAL RETENTION TEST; CALIFORNIA VERBAL LEARNING TEST; COGNITION; COGNITIVE DEFECT; DEMENTIA; EPISODIC MEMORY; EVIDENCE BASED PRACTICE; HOPKINS VERBAL LEARNING TEST; HUMAN; LIFESTYLE; MEDITERRANEAN DIET; MEMORY; META ANALYSIS; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; SYSTEMATIC REVIEW; TAI CHI; AGED; COGNITION DISORDERS; COGNITIVE AGING; DIETARY SUPPLEMENT; GINKGO BILOBA; LEARNING; MIDDLE AGED; PSYCHOLOGY; SOY FOOD;

AGED; COGNITION DISORDERS; COGNITIVE AGING; DIET, MEDITERRANEAN; DIETARY SUPPLEMENTS; GINKGO BILOBA; HUMANS; LEARNING; MEMORY, EPISODIC; MIDDLE AGED; OLIVE OIL; RISK FACTORS; SOY FOODS; TAI JI;

EID: 84941087404     PISSN: 13697137     EISSN: 14730804     Source Type: Journal    
DOI: 10.3109/13697137.2015.1078106     Document Type: Article

References (85)

1. Henderson VW. Three midlife strategies to prevent cognitive impairment due to Alzheimers disease. Climacteric 2014; 17 (Suppl 2): 38-46
2. Stern Y. Cognitive reserve in aging and Alzheimers disease. Lancet Neurol 2012; 11: 1006-12
3. Meng X, DArcy C. Education and dementia in the context of the cognitive reserve hypothesis: a systematic review with meta-analyses and qualitative analyses. PloS One 2012; 7: e38268
4. Gauthier S, Reisberg B, Zaudig M, et al. Mild cognitive impairment. Lancet 2006; 367: 1262-70
5. Harlow SD, Gass M, Hall JE, et al. Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging. Climacteric 2012; 15: 105-14
6. Feldman HA, Longcope C, Derby CA, et al. Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts Male Aging Study. J Clin Endocrinol Metab 2002; 87: 589-98
7. Williams JW, Plassman BL, Burke J, Holsinger T, Benjamin S. Preventing Alzheimers Disease and Cognitive Decline. Evidence Report/Technology Assessment Number 193. AHRQ Publication No. 10-E005. Rockville, MD: Department of Health and Human Services, 2010
8. Villaseca P. Non-estrogen conventional and phytochemical treatments for vasomotor symptoms: what needs to be known for practice. Climacteric 2012; 15: 115-24
9. Song F, Parekh S, Hooper L, et al. Dissemination and publication of research findings: an updated review of related biases. Health Technol Assess 2010; 14: 1-193
10. Albert MS, Dekosky ST, Dickson D, et al. The diagnosis of mild cognitive impairment due to Alzheimers disease: Recommendations from the National Institute on Aging and Alzheimers Association workgroup. Alzheimers Dement 2011; 7: 270-9
11. Rucker G. Network meta-analysis, electrical networks and graph theory. Res Synth Methods 2012; 3: 312-24
12. Krahn U, Binder H, Konig J. A graphical tool for locating inconsistency in network meta-analyses. BMC Med Res Methodol 2013; 13: 35
13. Lumley T. Network meta-analysis for indirect treatment comparisons. Stat Med 2002; 21: 2313-24
14. Rücker G, Schwarzer G, Krahn U, Jochem König J. Package netmeta, version 0.8-0, network meta-analysis using frequentist methods. R Library, Repository CRAN. 2015-06-26 18: 23: 34
15. Shen L, Ji HF. Associations between homocysteine, folic acid, vitamin B12 and Alzheimers disease: insights from meta-analyses. J Alzheimers Dis 2015. April 8. Epub ahead of print
16. Homocysteine Lowering Trialists Collaboration. Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials. BMJ 1998; 316:894- 8
17. Douaud G, Refsum H, de Jager CA, et al. Preventing Alzheimers disease-related gray matter atrophy by B-vitamin treatment. Proc Natl Acad Sci USA 2013; 110: 9523-8
18. Ford AH, Almeida OP. Effect of homocysteine lowering treatment on cognitive function: a systematic review and meta-analysis of randomized controlled trials. J Alzheimers Dis 2012; 29: 133-49
19. Durga J, van Boxtel MP, Schouten EG, et al. Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: a randomised, double blind, controlled trial. Lancet 2007; 369: 208-16
20. McMahon JA, Green TJ, Skeaff CM, Knight RG, Mann JI, Williams SM. A controlled trial of homocysteine lowering and cognitive performance. N Engl J Med 2006; 354: 2764-72
21. van der Zwaluw NL, Dhonukshe-Rutten RA, van Wijngaarden JP, et al. Results of 2-year vitamin B treatment on cognitive performance: secondary data from an RCT. Neurology 2014; 83: 2158-66
22. Ford AH, Flicker L, Alfonso H, et al. Vitamins B(12), B(6), and folic acid for cognition in older men. Neurology 2010; 75: 1540-7
23. Grimley Evans J, Malouf R, Huppert F, van Niekerk JK. Dehydroepiandrosterone (DHEA) supplementation for cognitive function in healthy elderly people. Cochrane Database Syst Rev 2006:C D006221
24. Kritz-Silverstein D, von Muhlen D, Laughlin GA, Bettencourt R. Effects of dehydroepiandrosterone supplementation on cognitive function and quality of life: the DHEA and Well-Ness (DAWN) Trial. J Am Geriatr Soc 2008; 56: 1292-8
25. Tan MS, Yu JT, Tan CC, et al. Efficacy and adverse effects of Ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis. J Alzheimers Dis 2015; 43: 589-603
26. Vellas B, Coley N, Ousset PJ, et al. Long-term use of standardised Ginkgo biloba extract for the prevention of Alzheimers disease (GuidAge): a randomised placebo-controlled trial. Lancet Neurol 2012; 11: 851-9
27. DeKosky ST, Williamson JD, Fitzpatrick AL, et al. Ginkgo biloba for prevention of dementia: a randomized controlled trial. JAMA 2008; 300: 2253-62
28. Snitz BE, OMeara ES, Carlson MC, et al. Ginkgo biloba for preventing cognitive decline in older adults: a randomized trial. JAMA 2009; 302: 2663-70
29. Dodge HH, Zitzelberger T, Oken BS, Howieson D, Kaye J. A randomized placebo-controlled trial of Ginkgo biloba for the prevention of cognitive decline. Neurology 2008; 70: 1809-17
30. Singh B, Parsaik AK, Mielke MM, et al. Association of Mediterranean diet with mild cognitive impairment and Alzheimers disease: a systematic review and meta-analysis. J Alzheimers Dis 2014; 39: 271-82
31. Samieri C, Grodstein F, Rosner BA, et al. Mediterranean diet and cognitive function in older age. Epidemiology 2013; 24: 490-9
32. Martinez-Lapiscina EH, Clavero P, Toledo E, et al. Mediterranean diet improves cognition: the PREDIMED-NAVARRA randomised trial. J Neurol Neurosurg Psychiatry 2013; 84: 1318-25
33. Martinez-Lapiscina EH, Clavero P, Toledo E, et al. Virgin olive oil supplementation and long-term cognition: the PREDIMED-NAVARRA randomized trial. J Nutr Health Aging 2013; 17: 544-52
34. Valls-Pedret C, Sala-Vila A, Serra-Mir M, et al. Mediterranean diet and age-related cognitive decline: a randomized clinical trial. JAMA Intern Med 2015; 175: 1094-103
35. Weber MT, Maki PM, McDermott MP. Cognition and mood in perimenopause: a systematic review and meta-analysis. J Steroid Biochem Mol Biol 2014; 142: 90-8
36. Hogervorst E, Bandelow S. Sex steroids to maintain cognitive function in women after the menopause: a meta-analysis of treatment trials. Maturitas 2010; 66: 56-71
37. Shumaker SA, Legault C, Kuller L, et al. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Womens Health Initiative Memory Study. JAMA 2004; 291: 2947-58
38. Henderson VW, Espeland MA, Hogan PE, et al. Prior use of hormone therapy and incident Alzheimer's disease in the Women's Health Initiative Memory Study [abstract]. Neurology 2007; 68 (Suppl 1): A205
39. Henderson VW. Alzheimers disease: Review of hormone therapy trials and implications for treatment and prevention after menopause. J Steroid Biochem Mol Biol 2014; 142: 99-106
40. Rapp SR, Espeland MA, Shumaker SA, et al. The effect of estrogen with progestin treatment on global cognitive function in postmenopausal women: results from the Womens Health Initiative Memory Study. JAMA 2003; 289: 2663-72
41. Espeland MA, Rapp SR, Shumaker SA, et al. Conjugated equine estrogens and global cognitive function in postmenopausal women: Womens Health Initiative Memory Study. JAMA 2004; 291: 2959-68
42. Resnick SM, Maki PM, Rapp SR, et al. Effects of combination estrogen plus progestin hormone treatment on cognition and affect. J Clin Endocrinol Metab 2006; 91: 1802-10
43. Resnick SM, Espeland MA, An Y, et al. Effects of conjugated equine estrogens on cognition and affect in postmenopausal women with prior hysterectomy. J Clin Endocrinol Metab 2009; 94: 4152-61
44. Binder EF, Schechtman KB, Birge SJ, Williams DB, Kohrt WM. Effects of hormone replacement therapy on cognitive performance in elderly women. Maturitas 2001; 38: 137-46
45. Greenspan SL, Resnick NM, Parker RA. The effect of hormone replacement on physical performance in community-dwelling elderly women. Am J Med 2005; 118: 1232-9
46. Yaffe K, Vittinghoff E, Ensrud KE, et al. Effects of ultra-low-dose transdermal estradiol on cognition and health-related quality of life. Arch Neurol 2006; 63: 945-50
47. Tierney MC, Oh P, Moineddin R, et al. A randomized double-blind trial of the effects of hormone therapy on delayed verbal recall in older women. Psychoneuroendocrinology 2009; 37: 1065-74
48. Maki PM, Gast MJ, Vieweg A, Burriss SW, Yaffe K. Hormone therapy in menopausal women with cognitive complaints: a randomized, double-blind trial. Neurology 2007; 69: 1322-30
49. Gleason CE, Dowling NM, Wharton W, et al. Effects of hormone therapy on cognition and mood in recently postmenopausal women: findings from the randomized, controlled KEEPS-cognitive and affective study. PLoS Med 2015; 12: e1001833
50. Henderson VW, St.John JA, Hodis HN, et al. Cognition, mood, and physiological concentrations of sex hormones in the early and late postmenopause. Proc Natl Acad Sci USA 2013; 110: 20290-5
51. Wayne PM, Walsh JN, Taylor-Piliae RE, et al. Effect of Tai Chi on cognitive performance in older adults: systematic review and meta-analysis. J Am Geriatr Soc 2014; 62: 25-39
52. Oken BS, Zajdel D, Kishiyama S, et al. Randomized, controlled, six-month trial of yoga in healthy seniors: effects on cognition and quality of life. Altern Ther Health Med 2006; 12: 40-7
53. Taylor-Piliae RE, Newell KA, Cherin R, Lee M, King AC, Haskell WL. Tai Chi versus Western exercise on physical and cognitive functioning in healthy community-dwelling older adults: a randomized clinical trial. J Aging Phys Act 2010; 18: 261-79
54. Mortimer JA, Ding D, Borenstein AR, et al. Changes in brain volume and cognition in a randomized trial of exercise and social interaction in a community-based sample of non-demented Chinese elders. J Alzheimers Dis 2012; 30: 757-66
55. Sydenham E, Dangour AD, Lim WS. Omega 3 fatty acid for the prevention of cognitive decline and dementia. Cochrane Database Syst Rev 2012:C D005379
56. Cukierman-Yaffe T, Bosch J, Diaz R, et al. Effects of basal insulin glargine and omega-3 fatty acid on cognitive decline and probable cognitive impairment in people with dysglycaemia: a substudy of the ORIGIN trial. Lancet Diabetes Endocrinol 2014; 2: 562-72
57. van de Rest O, Geleijnse JM, Kok FJ, et al. Effect of fish oil on cognitive performance in older subjects: a randomized, controlled trial. Neurology 2008; 71: 430-8
58. Dangour AD, Allen E, Elbourne D, et al. Effect of 2-y n-3 long-chain polyunsaturated fatty acid supplementation on cognitive function in older people: a randomized, double-blind, controlled trial. Am J Clin Nutr 2010; 91: 1725-32
59. Carlson MC, Saczynski JS, Rebok GW, et al. Exploring the effects of an "everyday" activity program on executive function and memory in older adults: Experience Corps. Gerontologist 2008; 48: 793-801
60. White LR, Petrovitch H, Ross GW, et al. Brain aging and midlife tofu consumption. J Am Coll Nutr 2000; 19: 242-55
61. Soni M, Rahardjo TB, Soekardi R, et al. Phytoestrogens and cognitive function: a review. Maturitas 2014; 77: 209-20
62. Kritz-Silverstein D, Von Muehlen D, Barrett-Connor E, Bressel MAB. Isoflavones and cognitive function in older women: the SOy and Postmenopausal Health in Aging (SOPHIA) Study. Menopause 2003; 10: 196-202
63. Henderson VW, St John JA, Hodis HN, et al. Long-term soy isoflavone supplementation and cognition in women: A randomized, controlled trial. Neurology 2012; 78: 1841-8
64. Ho SC, Chan AS, Ho YP, et al. Effects of soy isoflavone supplementation on cognitive function in Chinese postmenopausal women: a double-blind, randomized, controlled trial. Menopause 2007; 14: 489-99
65. Kreijkamp-Kaspers S, Kok L, Grobbee DE, et al. Effect of soy protein containing isoflavones on cognitive function, bone mineral density, and plasma lipids in postmenopausal women: a randomized controlled trial. JAMA 2004; 292: 65-74
66. St John JA, Henderson VW, Hodis HN, et al. Associations between urine excretion of isoflavonoids and cognition in postmenopausal women in the Womens Isoflavone Soy Health clinical trial. J Am Geriatr Soc 2014; 62: 629-35
67. Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357: 266-81
68. Annweiler C, Montero-Odasso M, Llewellyn DJ, Richard-Devantoy S, Duque G, Beauchet O. Meta-analysis of memory and executive dysfunctions in relation to vitamin D. J Alzheimers Dis 2013; 37: 147-71
69. Balion C, Griffith LE, Strifler L, et al. Vitamin D, cognition, and dementia: a systematic review and meta-analysis. Neurology 2012; 79: 1397-405
70. Ross AC, Taylor CL, Yaktine AL, Del Valle HB., eds. Dietary Reference Intakes for Calcium and Vitamin D. Washington, DC: National Academies Press, 2011
71. Rossom RC, Espeland MA, Manson JE, et al. Calcium and vitamin D supplementation and cognitive impairment in the Womens Health Initiative. J Am Geriatr Soc 2012; 60: 2197-205
72. Ball K, Berch DB, Helmers KF, et al. Effects of cognitive training interventions with older adults: a randomized controlled trial. JAMA 2002; 288: 2271-81
73. Rebok GW, Ball K, Guey LT, et al. Ten-year effects of the advanced cognitive training for independent and vital elderly cognitive training trial on cognition and everyday functioning in older adults. J Am Geriatr Soc 2014; 62: 16-24
74. Kelly ME, Loughrey D, Lawlor BA, Robertson IH, Walsh C, Brennan S. The impact of cognitive training and mental stimulation on cognitive and everyday functioning of healthy older adults: a systematic review and meta-analysis. Ageing Res Rev 2014; 15: 28-43
75. Reijnders J, van Heugten C, van Boxtel M. Cognitive interventions in healthy older adults and people with mild cognitive impairment: a systematic review. Ageing Res Rev 2013; 12: 263-75
76. Sofi F, Valecchi D, Bacci D, et al. Physical activity and risk of cognitive decline: a meta-analysis of prospective studies. J Intern Med 2011; 269: 107-17
77. Geda YE, Roberts RO, Knopman DS, et al. Physical exercise, aging, and mild cognitive impairment: a population-based study. Arch Neurol 2010; 67: 80-6
78. Erickson KI, Voss MW, Prakash RS, et al. Exercise training increases size of hippocampus and improves memory. Proc Natl Acad Sci USA 2011; 108: 3017-22
79. Young J, Angevaren M, Rusted J, Tabet N. Aerobic exercise to improve cognitive function in older people without known cognitive impairment. Cochrane Database Syst Rev 2015; 4: CD005381
80. Kramer AF, Hahn S, McAuley E, et al. Exercise, aging and cognition: healthy body, healthy mind? In Fish AD, Rogers W., eds. Human Factors Interventions for the Health Care of Older Adults. Hillsdale, NJ: Erlbaum, 2001: 91-120
81. Messina M, Nagata C, Wu AH. Estimated Asian adult soy protein and isoflavone intakes. Nutr Cancer 2006; 55: 1-12
82. de Villiers TJ, Pines A, Panay N, et al. Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health. Climacteric 2013; 16: 316-37
83. Shifren JL, Gass ML., NAMS Recommendations for Clinical Care of Midlife Women Working Group. The North American Menopause Society recommendations for clinical care of midlife women. Menopause 2014; 21: 1038-62
84. Ngandu T, Lehtisalo J, Solomon A, et al. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial. Lancet 2015; 385: 2255-63
85. Salthouse TA. When does age-related cognitive decline begin? Neurobiol Aging 2009; 30: 507-14